A Heart-Breaking Finding By Richard Miller (London)

Research from the University of Oxford has shown that 1 in 100 or 1 percent of all vaccinated individuals were admitted to the hospital or died with arrhythmia or irregular heartbeat. Guess why this does not make international headlines, while religious leaders like the Archbishop of Canterbury proclaim that the vaxxes are an answer to a prayer. Whose prayer?

https://www.nature.com/articles/s41591-021-01630-0

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

• Martina Patone, 
• Xue W. Mei, 
• Lahiru Handunnetthi, 
• Sharon Dixon, 
• Francesco Zaccardi, 
• Manu Shankar-Hari, 
• Peter Watkinson, 
• Kamlesh Khunti, 
• Anthony Harnden, 
• Carol A. C. Coupland, 
• Keith M. Channon, 
• Nicholas L. Mills, 
• Aziz Sheikh& 
• Julia Hippisley-Cox

Nature Medicine (2021)Cite this article

• 230k Accesses
• 5499 Altmetric
• Metricsdetails

Abstract

Although myocarditis and pericarditis were not observed as adverse events in coronavirus disease 2019 (COVID-19) vaccine trials, there have been numerous reports of suspected cases following vaccination in the general population. We undertook a self-controlled case series study of people aged 16 or older vaccinated for COVID-19 in England between 1 December 2020 and 24 August 2021 to investigate hospital admission or death from myocarditis, pericarditis and cardiac arrhythmias in the 1–28 days following adenovirus (ChAdOx1, n = 20,615,911) or messenger RNA-based (BNT162b2, n = 16,993,389; mRNA-1273, n = 1,006,191) vaccines or a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive test (n = 3,028,867). We found increased risks of myocarditis associated with the first dose of ChAdOx1 and BNT162b2 vaccines and the first and second doses of the mRNA-1273 vaccine over the 1–28 days postvaccination period, and after a SARS-CoV-2 positive test. We estimated an extra two (95% confidence interval (CI) 0, 3), one (95% CI 0, 2) and six (95% CI 2, 8) myocarditis events per 1 million people vaccinated with ChAdOx1, BNT162b2 and mRNA-1273, respectively, in the 28 days following a first dose and an extra ten (95% CI 7, 11) myocarditis events per 1 million vaccinated in the 28 days after a second dose of mRNA-1273. This compares with an extra 40 (95% CI 38, 41) myocarditis events per 1 million patients in the 28 days following a SARS-CoV-2 positive test. We also observed increased risks of pericarditis and cardiac arrhythmias following a positive SARS-CoV-2 test. Similar associations were not observed with any of the COVID-19 vaccines, apart from an increased risk of arrhythmia following a second dose of mRNA-1273. Subgroup analyses by age showed the increased risk of myocarditis associated with the two mRNA vaccines was present only in those younger than 40.